How to buy STERIS (STE) stocks

STERIS is a medical devices business based in the US. STERIS shares (STE) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $207.49 – a decrease of 3.14% over the previous week. STERIS employs 18,000 staff and has a trailing 12-month revenue of around $5.3 billion.

Our top picks for where to buy STERIS stock

Buy STERIS stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

STERIS stock price (NYSE: STE)

Use our graph to track the performance of STE stocks over time.

STERIS stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$207.49
52-week range	$196.38 - $247.59
50-day moving average more info button	$220.34
200-day moving average more info button	$224.80
Wall St. target price	$249.39
PE ratio more info button	34.8502
Dividend yield more info button	$2.13 (1.1%)
Earnings per share (TTM) more info button	$5.94

Is it a good time to buy STERIS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

STERIS price performance over time

Historical closes compared with the close of $207.49 from 2024-12-20

1 week (2024-12-13)	-3.14%
1 month (2024-11-22)	-3.20%
3 months (2024-09-20)	-12.44%
6 months (2024-06-21)	-4.87%

1 year (2023-12-22)	-5.60%
2 years (2022-12-22)	16.31%
3 years (2021-12-22)	228.2734
5 years (2019-12-20)	44.95%

Is STERIS stock undervalued or overvalued?

Valuing STERIS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STERIS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STERIS's P/E ratio

STERIS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, STERIS shares trade at around 35x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

STERIS's PEG ratio

STERIS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1582. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into STERIS's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

STERIS's EBITDA

STERIS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.

The EBITDA is a measure of a STERIS's overall financial performance and is widely used to measure a its profitability.

STERIS financials

Revenue TTM	$5.3 billion
Operating margin TTM	16.98%
Gross profit TTM	$2.2 billion
Return on assets TTM	5.45%
Return on equity TTM	9.27%
Profit margin	8.16%
Book value	$66.80
Market Capitalization more info button	$20.4 billion

TTM: trailing 12 months

STERIS stock dividends

Dividend payout ratio: 24.01% of net profits

Recently STERIS has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), STERIS shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In STERIS's case, that would currently equate to about $2.13 per share.

While STERIS's payout ratio might seem low, this can signify that STERIS is investing more in its future growth.

STERIS's most recent dividend payout was on 18 December 2024. The latest dividend was paid out to all shareholders who bought their stocks by 18 November 2024 (the "ex-dividend date").

Have STERIS's stocks ever split?

STERIS's stocks were split on a 2:1 basis on 24 August 1998 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your STERIS stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for STERIS stocks, which in turn could have impacted STERIS's stock price.

STERIS stock price volatility

Over the last 12 months, STERIS's stocks have ranged in value from as little as $196.3788 up to $247.5882. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while STERIS's is 0.851. This would suggest that STERIS's stocks are less volatile than average (for this exchange).

STERIS overview

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of STERIS is owned by insiders or institutions?
Currently 0.294% of STERIS stocks are held by insiders and 98.53% by institutions. How many people work for STERIS?
Latest data suggests 18,000 work at STERIS. When does the fiscal year end for STERIS?
STERIS's fiscal year ends in March. Where is STERIS based?
STERIS's address is: 5960 Heisley Road, Mentor, OH, United States, 44060 What is STERIS's ISIN number?
STERIS's international securities identification number is: IE00BFY8C754 What is STERIS's CUSIP number?
STERIS's Committee on Uniform Securities Identification Procedures number is: G8473T100

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.